Dr Reddy's Laboratories reports 7% rise in Q2 consolidated net profit

24 Oct 2025 Evaluate

Dr Reddy's Laboratories has reported result for second quarter ended September 30, 2025 (Q2FY26).

The company has reported 79.42% fall in its net profit at Rs 387.30 crore for the quarter ended September 30, 2025 as compared to Rs 1882.10 crore for the same quarter in the previous year. The total income of the company decreased by 27.83% at Rs 4982.80 crore for Q2FY26 as compared to Rs 6903.90 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 7.28% rise in its net profit at Rs 1347.10 crore for Q2FY26 as compared to Rs 1255.70 crore for the same quarter in the previous year. The total income of the company increased by 9.66% at Rs 9152.20 crore for Q2FY26 as compared to Rs 8345.70 crore for the corresponding quarter previous year.

Dr. Reddys Lab Share Price

1175.55 -10.90 (-0.92%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×